Concepedia

Mary‐Elizabeth M. Percival

MM

16

Publications

884

Citations

13

H-Index

2015

Active since

Affiliations

Fred Hutch Cancer Center(Current)

University of Washington

Seattle Cancer Care Alliance

University of Washington Medical Center

Sarah Cannon

Mary‐Elizabeth M. Percival is an author at Fred Hutch Cancer Center specializing in medicine, hematology, and oncology.

ORCID

Top concepts

Publications per year

2015–2024

16

Publications

16

NCCN Guidelines Insights: Acute Myeloid Leukemia, Version 2.2021

Daniel A. Pollyea, Dale L. Bixby, Alexander E. Perl et al. · Journal of the National Comprehensive Cancer Network · 2021 · 314 citations · Full text

, , +13

Phase I Study of the CD47 Blocker TTI-621 in Patients with Relapsed or Refractory Hematologic Malignancies

Stephen M. Ansell, Michael B. Maris, Alexander M. Lesokhin et al. · Clinical Cancer Research · 2021 · 183 citations · Full text

Improvements in the early death rate among 9380 patients with acute myeloid leukemia after initial therapy: A SEER database analysis

Mary‐Elizabeth M. Percival, Tao Li, Bruno C. Medeiros et al. · Cancer · 2015 · 67 citations · Full text

Phase 1/2 trial of GCLAM with dose-escalated mitoxantrone for newly diagnosed AML or other high-grade myeloid neoplasms

Anna B. Halpern, Megan Othus, Emily M. Huebner et al. · Leukemia · 2018 · 49 citations · Full text

, , +8

Accuracy of SIE/SIES/GITMO Consensus Criteria for Unfitness to Predict Early Mortality After Intensive Chemotherapy in Adults With AML or Other High-Grade Myeloid Neoplasm

Raffaele Palmieri, Megan Othus, Anna B. Halpern et al. · Journal of Clinical Oncology · 2020 · 49 citations · Full text

Rows per page

1–5 of 16